Sign In
Register

Partner with us

Register

Call to action
Your text goes here. Insert your content, thoughts, or information in this space.
Button

Back to speakers

Jonathan
Sheffi
Vice President of Strategy & Product
Clarivate
Jonathan Sheffi is the VP of Strategy & Product Excellence for the Life Sciences & Healthcare division of Clarivate. Previously, he served as the first-ever Entrepreneur in Residence at Veeva Systems, a leading provider of SaaS to the life sciences industry, and was the product leader for life sciences at Google Cloud. He also cofounded Curoverse, which built an open source platform for managing and processing biomedical data (acquired by Veritas Genetics). His past leadership also includes roles with Novartis Diagnostics, Amgen, Accenture, and the Broad Institute. He holds an MBA from Harvard, and an MEng in computational molecular biology from MIT.
Button
28 October 2026 15:30 - 16:00
Lower the cost of being wrong: Experimentation for teams that never get the sample size
Most slow product teams aren't timid. They're rationally careful, because finding out you were wrong is expensive where they work. Research gets shaped to fit the plan, roadmaps drift toward whoever spoke last, and nearly everything in the backlog is a "must have." Asking people to be braver doesn't fix that. Making it cheap to change your mind does. Jonathan Sheffi's division is becoming a standalone company, which gave his team the chance to rewrite how product works. He shares the diagnosis they wrote and the plan they are starting to run: Write down what would change your mind before you do the research (a rule borrowed from clinical trials), make "no" a safe answer for the person who finds it, and make fewer commitments and keep them. This is experimentation for enterprise teams, where a test is a dozen customer conversations.